Cannabis

Global spending on legal cannabis is expected to grow 230% to $31.3% billion in 2022 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. The research projects a majority of that, nearly $23.4 billion will come from the United States. In context of more states voting in favor of marijuana use legalization and business interest sparking across the board, that definitely would make sense.

In the year through January 11, 2019, the United States Marijuana Index, fell 20.7%, as compared to about 6.5% loss seen by the S&P 500. Given that is not exactly an apples to apples comparison, but it does make a case to at least investigate investments in marijuana stocks. (May 6, 2019, Mrinalini Krishna, Investopedia)

Canada launched Cannabis 2.0 products last year and several Canadian cannabis stocks have been positioning themselves to leverage opportunities of this second green rush. Although the COVID-19 pandemic affected most sectors, for the cannabis sector it has been a blessing in disguise as most operators witnessed demand surge for...
Canadian Cannabis stocks have been hot in recent weeks as most benefitted from the demand in cannabis products during the lockdown. Although in the past year most cannabis stocks were facing financial issues some have implemented turnaround strategies and are surprisingly performing well. GW Pharmaceuticals waiting for approval of Epidiolex...
The COVID-19 pandemic has wreaked havoc across equity markets but Canadian Cannabis stocks have been lucky. The anxiety and chaos resulting from the pandemic led to most people turning to cannabis for relief which created high sales for some Canadian cannabis companies. Here are some stocks expected to continue...
Global equity markets have been experiencing volatility but Canadian cannabis stocks have comparatively in the safer side. The surge in demand for cannabis during the COVID-19 induced lockdowns boosted pot companies. Here are some big names poised to continue performing exceptionally. Aphria expected to grow sales with licensing of more...
Over the past year, the cannabis industry has experienced a lot of volatility and Canadian Cannabis stocks lost most of their value. The COVID-19 deepened the crisis and some of the stocks are unlikely to survive. However, there are some that are in strong positions to survive the crisis...
Canadian cannabis stocks have been less appealing to investors because of volatility caused by the COVID-19 crisis. However, the industry still has potential and in the next few years, the cannabis sector will truly live to its potential. Here are some stocks showing a lot of potentials. Aurora rightsizing as...
In the last two years, the cannabis industry has faced a myriad of challenges but the COVID-19 pandemic has brought new realities for Canadian cannabis stocks. Cannabis stocks experienced a surge in demand for pot during the COVID-19 lockdown leading to several operators reporting exceptional results in the recent...
Canadian cannabis stocks have been facing a myriad of challenges since the legalization of marijuana in the country. One of the biggest challenges for operators has been regulatory issues with Health Canada and slow licensing of retail dispensaries. The slow process of licensing dispensaries has hamstrung operators and the...
Canadian Cannabis stocks have had a torrid past year but amid the coronavirus pandemic there has been a surge in demand and some of the operators have reported exceptional results. In recent weeks several Canadian cannabis stocks have been hot owing to an exceptional first quarter of 2020. Although...
When 2018 there was much expectation and most Canadian cannabis stocks began positioning themselves to reap the gains of the nascent sector. Most companies have been struggling with cash problems and although the coronavirus pandemic might have halted operations several operators have reported an increase in sales in the...